ä»æã®æ¥çµç¤¾èª¬ï¼ NIKKEI NETï¼ç¤¾èª¬ã»æ¥ç§ ãã¥ã¼ã¹: "ç±³å½ã¨éå½ãä»å¹´æ«ã¾ã§ã®åæãç®æ¨ã«èªç±è²¿æåå®ï¼ï¼¦ï¼´ï¼¡ï¼ã®ç· çµäº¤æ¸ã«å ¥ã£ããç±³ããã·ã¥æ¿æ¨©ã¯æ±ã¢ã¸ã¢å°åã§æãç·å¯ãªé¢ä¿ã«ããæ¥æ¬ã«å ããã¦ãéå½ãå¸å ´çµ±åã®ç¬¬ä¸ã®äº¤æ¸ç¸æå½ã«é¸ãã ã"ãªããï¼ çç±ã¯æ¥æ¬ã®è¾²æ°ã«ãããç±³å½æ¿åºé«å®ã¯ãããã£ã¦ããï¼ çµæ¸çã®æå¾ ã«åããæ¥ç±³ä¸¡å½æ¿åºã®ç±æã¯é«ã¾ããªããç±³éå代表é¨ï¼ï¼µï¼³ï¼´ï¼²ï¼ã®é«å®ã¯ããã®çç±ã¨ãã¦ãæ¥æ¬ã®è¾²ç£ç©å¸å ´ã®éæ¾ãæ¿æ²»çã«é£ãããããã¨èªã£ã¦ãããåããã交æ¸é£èªãäºæ³ãããããä½è¨ãªæ¿æ²»çãªã¹ã¯ã¯åããããªãã¨ããå¤æã§ããã æ¥æ¬ã®è¾²æ¥å£ä½ã¯ããããéã®æ¿æ²»åã«ãããã®ç±³å½ãåã³è °ã«ãªã£ãããã¦ãã£ãããã¨å¤§åã³ãã¦ããã®ã ããããç±³å½ã«ã¾ã§è¦æ¾ãããFTAã®ææã¨ãã¦ç±³å½å¸å ´ã¯éå½ã«åããããã¨ã«ãªããæ¥æ¬å½æ°ã¯è¸ãã ãè¹´ã£ããã ã ä»åã®éå½ã®æ±ºæã¯ã¨ã©
å¯å£«ã¬ããªãJanssenã¨ã¢ã«ããã¤ãã¼çæ²»çè¬ã®ãã¤ãªãã¼ã«ã¼éçºã¸(2018.05.02) ã¿ãããã¼ã«ã³ãã£ã³ã°ã¹åä¸ã®å¯å£«ã¬ããªã¯ã2018å¹´5æ1æ¥ãç±³Janssen Pharmaceuticals社ã¨ãã¢ã«ããã¤ãã¼åèªç¥çã®æ£è ãªã©ã対象ã«ãã¢ããã¤ãβ42ã¨ã¢ããã¤ãβ40ã®å... Canon BioMedical社ãåç±³ã§MBS社ã®æ¬¡ä¸ä»£åPCRã·ã¹ãã ã販売ã¸(2018.05.02) ç±³Tocagen社ãä¸å½ApolloBio社ã¸è «ç溶解ã¦ã¤ã«ã¹è£½å¤Toca 511ãå°åº(2018.05.02) ç±³Rallybio社ã3700ä¸ãã«èª¿éãéçå¸å°ç¾æ£æ²»çè¬ã®éçºæ¨é²(2018.05.02) AACR2018 é²è¡æªæ§é»è²è «ã§æPD1æä½èæ§ã®æ£è ã«TLA9ã¢ã´ãã¹ãCMP-001ã¨ãã ãããªãºããã®ä½µç¨ãææ(2018.05.02) ããã³ãã£ã¢ã®æ¯è²ââãã¤ãªãã
â»è¾²å®¶ãã¿ã¯ãã®ä¸ã®è¨äºããå§ã¾ãã¾ãã WCã®é°ã«é ãã¦ã èªæ°å ã¨æ°ä¸»å ãã¨ãã§ããªãæ³æ¡ãå¯æ±ºãã¦ãã¾ãã¾ããã â é常äºæ çºçï¼ï¼éã«æ¥æ¬ã«æ鮮人ãæ¼ãå¯ããæ³æ¡ãå¯æ±ºãæç«ï¼ï¼ï¼ â èªæ°å ãæ¬æ¥æ¨é²ãã¦ãããåæ鮮人権æ³æ¡ãã¨ã¯ãåã¸ã®ãçµæ¸å¶è£ã®ã¿ã®æ³æ¡ãã§ããã ããã«å¯¾ãæ°ä¸»å ãäºæã«ãåæ鮮人権侵害ææ¸æ³æ¡ãã¨ãã¦ãç¬èªæ¡ããå½ä¼æåºã ããã¯ãè±åè ãé£æ°ã¨èªå®ããæ¥æ¬ã®å®ä½è³æ ¼ãä¸ãããã¨ããæ¡é ãçãè¾¼ãã ãã®ã§ãã æ³æ¡æç«ãæ¥ãèªæ°å ã¯ãããã¸æ¥ã¦æ°ä¸»æ¡ï¼è±åè æ¯æ´ï¼ãåãå ¥ããèãã«æ¹éã転æ⦠è±åè æ¯æ´ã«ã¤ãã¦ãæ½çãè¬ããããåªãããã®æè¨ã§åæãã13æ¥è¡é¢ãééã ããã¦16æ¥ãæ³æ¡ã¯ä¿®æ£ããã¬ã¾ã¾èªå ¬æ°3å ãªã©ã®è³æå¤æ°ã§å¯æ±ºãæç«ãã¾ããã ã¹ãã¤é²æ¢æ³ããç¡ãæ¥æ¬ãè±åè ã®ç§»ä½ãæ¯æ´ããè±åè æ¯æ´NGOã«ã¾ã§è¡ç¨ãæå ¥â¦ orz ãããª
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}